期刊文献+

咪达唑仑通过下调circASXL1抑制胃癌细胞增殖、迁移和侵袭 被引量:2

Midazolam inhibits the proliferation,migration and invasion of gastric cancer cells by down-regulating circASxL1
下载PDF
导出
摘要 目的探讨咪达唑仑对胃癌细胞增殖、迁移和侵袭的可能机制。方法体外培养胃癌HGC-27细胞,用不同剂量(10、20、40μmol/L)咪达唑仑干预24 h后,CCK-8法、克隆形成实验、Transwell分别检测细胞增殖抑制率、克隆数、迁移及侵袭,蛋白质印迹法检测细胞中E-cadherin和N-cadherin蛋白表达,qRT-PCR法检测细胞中circASXL1表达。分别以53例癌旁组织、胃黏膜上皮细胞GES-1为对照,qRT-PCR法检测53例胃癌组织和HGC-27细胞中circASXL1表达。同时,咪达唑仑干预HGC-27细胞24 h后,qRT-PCR法检测细胞中circASXL1表达。转染circASXL1小干扰RNA或过表达载体至HGC-27细胞,上述相同方法观察circASXL1对HGC-27细胞增殖、迁移和侵袭的影响。结果与对照组比较,HGC-27细胞经不同剂量咪达唑仑干预后,细胞增殖抑制率、E-cadherin蛋白表达均升高(P<0.05),细胞克隆数、迁移数、侵袭数及N-cadherin蛋白表达均降低(P<0.05)。胃癌组织中circASXL1的表达明显高于癌旁组织(P<0.05);胃癌HGC-27细胞中circASXL1表达明显高于GES-1细胞(P<0.05)。敲减circASXL1后,HGC-27细胞增殖抑制率、E-cadherin蛋白表达均升高(P<0.05),细胞克隆数、迁移数、侵袭数及N-cadherin蛋白表达均降低(P<0.05)。与对照组比较,不同剂量咪达唑仑降低了HGC-27细胞中circASXL1的表达,过表达circASXL1降低了咪达唑仑对HGC-27细胞增殖、迁移和侵袭的影响。结论咪达唑仑可能通过下调circASXL1抑制胃癌HGC-27细胞增殖、迁移和侵袭。 Objective To investigate the effect of midazolam on the proliferation,migration and invasion of gastric cancer cells and its possible mechanism.Methods HGC-27 cells of gastric cancer were cultured in vitro and treated with different doses(10,20,40μmol/L)of midazolam for 24 h,and then CCK-8 assay,clone formation assay,and Transwell were used to detect cell proliferation inhibition rate,clone number,migration and invasion,respectively.The protein expression of E-cadherin and N-cadherins in the cells were detected by Western blotting.The expression of circASXL1 in the cells was detected by qRT-PCR.With 53 cases of adjacent tissues and gastric mucosal epithelial cells GES-1 as controls,qRT-PCR method was used to detect the expression of circASXL1 in 53 cases of gastric cancer tissues and HGC-27 cells.At the same time,the expression of circASXL1 in HGC-27 cells that interfered by midazolam for 24 hours was detected by qRT-PCR.circASXL1 small interfering RNA or overexpression vector was transfected into HGC-27 cells,and the same methods as above were used to observe the effect of circASXL1 on the proliferation,migration and invasion of HGC-27 cells.Results Compared with the control group,after HGC-27 cells were interfered with different doses of midazolam,the cell proliferation inhibition rate and the protein expression of E-cadherin were increased(P<0.05),but the number of cell clone,migration and invasion,and the protein expression of N-cadherin were decreased(P<0.05).The expression of circASXL1 in gastric cancer tissue was significantly higher than that in adjacent tissues(P<0.05);the expression of circASXL1 in gastric cancer HGC-27 cells was significantly higher than that in GES-1 cells(P<o.05).After knocking down circASXL1,the cell proliferation inhibition rate and the protein expression of E-cadherin were increased(P<o.05),but the number of cell clone,migration and invasion,and the protein expression of N-cadherin were decreased(P<o.05).Compared with the control group,different doses of midazolam reduced the expression of circASXL1 in HGC-27 cells,and overexpression of circASXL1 reduced the effects of midazolam on the proliferation,migration and invasion of HGC-27 cells.Conclusion Midazolam may inhibit the proliferation,migration and invasion of gastric cancer HGC-27 cells by down-regulating circASXL1.
作者 汪峻羽 卢想 佟凯 程若竹 WANG Jun-yu;LU Xiang;TONG Kai(Department of Anesthesiology,Liaoyang Central Hospital,Liaoyang 111000,China)
出处 《中国实验诊断学》 2023年第4期471-476,共6页 Chinese Journal of Laboratory Diagnosis
关键词 咪达唑仑 胃癌 circASXL1 细胞增殖 迁移 侵袭 midazolam gastric cancer circASXLl cell proliferation migration invasion
  • 相关文献

参考文献5

二级参考文献28

  • 1陈国勤,顾莹莹,刘芳,胡帅尔,莫明聪,刘慕嫦,杨通.非小细胞肺癌预后相关免疫组化指标的表达及意义[J].中国热带医学,2006,6(10):1755-1756. 被引量:1
  • 2Baldwin G.S,Shulkes A. Gastrin,gastrin receptors and colorectal carcinoma[J].Gut,1998,(04):581-584.
  • 3Elias D,Quenet F,Goéré D. Current status and future directions in the treatment of peritoneal dissemination from colorectal carcinoma[J].Surgical Oncology Clinics of North America,2012,(04):611-623.
  • 4Nordt SP,Clark RF. Midazolam:a review of therapeutic uses and toxicity[J].Journal of Emergency Medicine,1997,(03):357-365.
  • 5Dundee JW,Halliday NJ,Harper KW. Midasolam.A review of its pharmacological properties and therapeutic use[J].Drugs,1984,(06):519-543.
  • 6Jiang J,Li MH,Inoue K. Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells:role in cell proliferation[J].Cancer Research,2007,(22):10929-10938.
  • 7He J,Efron JE. Screening for colorectal cancer[J].Advances in Surgery,2011.31-44.
  • 8Jemal A,Siegel R,Ward E. Cancer statistics,2008[J].CA:A Cancer Journal for Clinicians,2008,(02):71-96.
  • 9Lee HJ,Kim MS,Shin JM. The expression patterns of deubiquitinating enzymes,USP22 and Usp22[J].Gene Expression Patterns,2006,(03):277-284.
  • 10Zhang XY,Varthi M,Sykes SM. The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression[J].Molecules and Cells,2008,(01):102-111.

共引文献13

同被引文献16

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部